Kolibri
Acoustic bioproduction for gene therapies.
Founded
2021
Founders
Amélie Quilichini, Founding CEO
Gabriel Dumy, CTO
Kolibri applies acoustic-based agitation to streamline viral vector production for gene therapies. Biomanufacturers benefit from higher yields, consistent batch quality, and reduced process times—addressing key bottlenecks in advanced therapy manufacturing.
Related
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA therapeutics platform.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.
Adbrain
Adbrain
Cross-device identity for personalized marketing.
Cofounder
Cofounder
Affable
Affable
AI analytics for influencer campaigns.